Clinical trials: Insomnia (Moderate)
- Condition Insomnia (Moderate)
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Insomnia, Hepatic Impairment
Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Mild, Moderate and Normal Hepatic Impairment
Primary Objectives: To evaluate the effect of the subjects with mild (Child Pugh A), moderate (Child Pugh B) and normal hepatic impairment on the pharmacokinetics of YZJ-1139 Secondary Objectives: To evaluate the safety of a…
- Trial name
- NCT06671509
- Testing
- YZJ-1139
- Where
- China
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Moderate to Severe Insomnia
HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With Moderate-to-Severe Insomnia
A prospective, decentralized, individually-randomized, triple-blind* sham-controlled, superiority trial to evaluate the safety and efficacy of HALO Clarity™ device in reducing insomnia severity.
- Trial name
- NCT07659366
- Testing
- Transcranial alternating current stimulator
- Where
- United States
- Volunteers
- 160 people, healthy volunteers welcome
- Sponsor
- Nexalin Technology
Insomnia
Evaluation of a Food Supplement on Sleep Quality
The purpose of this study is to evaluate the efficacy on sleep quality of a food supplement.
- Trial name
- Cyclamax (NCT00484497)
- Testing
- cyclamax
- Where
- France
- Volunteers
- 105 people, healthy volunteers welcome
- Sponsor
- Persee Medica